18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Adrian
A
Tempescul
Solene
S
Querellou
Jean-Christophe
JC
Ianotto
Sylvie
S
Boisramé
Gerald
G
Valette
Christian
C
Berthou
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000188:drug therapy; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D010255:Paranasal Sinus Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy; D010256:Paranasal Sinuses / Q000000981:diagnostic imaging / Q000473:pathology; D049268:Positron-Emission Tomography / Q000379:methods; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D012074:Remission Induction; D014055:Tomography, Emission-Computed / Q000379:methods; D014750:Vincristine / Q000008:administration & dosage
D009944:Organoplatinum Compounds; D003561:Cytarabine; D019788:Fluorodeoxyglucose F18; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone